Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.
Nov 23, 2017
0
4
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...
Nov 17, 2017
0
147
Malaria researchers at The Australian National University (ANU) have found one of the malaria parasite's best weapons against drug treatments turns out to be an Achilles' heel, which could be exploited to cure the deadly ...
Jul 25, 2016
0
0
A combination of artemisinin and another drug (artemisinin combination therapy, ACT) is currently the best malaria treatment recommended by the World Health Organization. In early 2015, artemisinin-resistant malaria was confirmed ...
Apr 11, 2016
0
0
Malaria is a worldwide menace. According to the Centers for Disease Control and Prevention, over 500,000 individuals died from malaria in 2013 alone. While treatments for the disease exist, cures can also take a hefty physical ...
Feb 25, 2016
0
0
George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages.
Nov 20, 2015
0
169
(HealthDay)—Metabolic syndrome is common in young, premenopausal women with systemic lupus erythematosus (SLE), and chloroquine appears to protect against metabolic syndrome in these women, according to a study published ...
Sep 17, 2015
0
8
(Medical Xpress)—Chloroquine (CQ) is a first-line treatment for Plasmodium falciparum infections, which like many other malaria treatments, eventually resulted in the selection of parasites with resistance to the drug. ...
A recent study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function on the ...
Aug 11, 2014
1
0
An anti-malarial treatment that lost its status as the leading weapon against the deadly disease could be given a new lease of life, with new research indicating it simply needs to be administered differently.
Apr 15, 2014
0
0
